- Filed
- Nov 5, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2015 · Oct 30, 2015 | 122.37M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2015 | 123.27M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2015 | 123.78M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2014 | 124.77M sh |
| Shares Diluted | Q3 2015 · Sep 30, 2014 | 124.78M sh |
| Stock Repurchased | Q3 2015 · Sep 30, 2015 | $91.17M |
| Dividends Paid | Q3 2015 · Sep 30, 2015 | $48.25M |
| Dividends Paid | Q3 2015 · Sep 30, 2014 | $42.77M |
| Capex | Q3 2015 · Sep 30, 2015 | $168.38M |
| Capex | Q3 2015 · Sep 30, 2014 | $148.84M |
| Operating Cash Flow | Q3 2015 · Sep 30, 2015 | $463.33M |
| Operating Cash Flow restated | Q3 2015 · Sep 30, 2014 | $414.52M |
| Long Term Debt | Q3 2015 · Sep 30, 2015 | $1.95B |
| Long Term Debt | Q3 2015 · Dec 31, 2014 | $1.97B |
| Short Term Debt | Q3 2015 · Sep 30, 2015 | $3.64M |
| Short Term Debt | Q3 2015 · Dec 31, 2014 | $3.65M |
| Cash And Equivalents | Q3 2015 · Sep 30, 2015 | $23.55M |
| Cash And Equivalents | Q3 2015 · Dec 31, 2014 | $14.35M |
| Cash And Equivalents | Q3 2015 · Sep 30, 2014 | $13.33M |
| Cash And Equivalents | Q3 2015 · Dec 31, 2013 | $13.59M |
| Stockholders Equity | Q3 2015 · Sep 30, 2015 | $1.94B |
| Stockholders Equity | Q3 2015 · Dec 31, 2014 | $2.23B |
| Current Liabilities | Q3 2015 · Sep 30, 2015 | $414.1M |
| Current Liabilities | Q3 2015 · Dec 31, 2014 | $360.31M |
| Total Liabilities | Q3 2015 · Sep 30, 2015 | $2.86B |
| Total Liabilities | Q3 2015 · Dec 31, 2014 | $3.01B |
| Current Assets | Q3 2015 · Sep 30, 2015 | $360.92M |
| Current Assets | Q3 2015 · Dec 31, 2014 | $366.14M |
| Total Assets | Q3 2015 · Sep 30, 2015 | $4.81B |
| Total Assets | Q3 2015 · Dec 31, 2014 | $5.25B |
| Eps Diluted | Q3 2015 · Sep 30, 2015 | −$2.08 |
| Eps Diluted | Q3 2015 · Sep 30, 2015 | −$1.19 |
| Eps Diluted | Q3 2015 · Sep 30, 2014 | $0.48 |
| Eps Diluted | Q3 2015 · Sep 30, 2014 | $1.38 |
| Eps Basic | Q3 2015 · Sep 30, 2015 | −$2.08 |
| Eps Basic | Q3 2015 · Sep 30, 2015 | −$1.19 |
| Eps Basic | Q3 2015 · Sep 30, 2014 | $0.48 |
| Eps Basic | Q3 2015 · Sep 30, 2014 | $1.38 |
| Sga Expense | Q3 2015 · Sep 30, 2015 | $59.8M |
| Sga Expense | Q3 2015 · Sep 30, 2015 | $175.21M |
| Sga Expense | Q3 2015 · Sep 30, 2014 | $57.99M |
| Sga Expense | Q3 2015 · Sep 30, 2014 | $170.16M |
| Net Income | Q3 2015 · Sep 30, 2015 | −$257.01M |
| Net Income | Q3 2015 · Sep 30, 2015 | −$147.83M |
| Net Income | Q3 2015 · Sep 30, 2014 | $60.08M |
| Net Income | Q3 2015 · Sep 30, 2014 | $171.76M |
| Operating Income | Q3 2015 · Sep 30, 2015 | −$375.15M |
| Operating Income | Q3 2015 · Sep 30, 2015 | −$163.26M |
| Operating Income restated | Q3 2015 · Sep 30, 2014 | $115.89M |
| Operating Income restated | Q3 2015 · Sep 30, 2014 | $334.28M |
| Cost Of Revenue | Q3 2015 · Sep 30, 2015 | $300.91M |
| Cost Of Revenue | Q3 2015 · Sep 30, 2015 | $879.47M |
| Cost Of Revenue | Q3 2015 · Sep 30, 2014 | $297.85M |
| Cost Of Revenue | Q3 2015 · Sep 30, 2014 | $847.86M |